Frequency of Anti-Toxoplasma IgM and IgG Antibodies in Leukemic Patients

Frequency of Anti-Toxoplasma IgM and IgG Antibodies in Leukemic Patients

Aim: the efficacy and safety of combined therapy with anticholinergics and alpha blockers in comparison with alpha blockers monotherapy among patients with BPH. Methods: We conducted a single blinded RCT and 80 patients with BPH who referred to Ali-ebn-abitaleb, Zahedan were included. One group rec...

Full description

Bibliographic Details
Main Authors:	M.J. Gharavi, M. Roozbehani, Z. Mandeh
Format:	Article
Language:	fas
Published:	Alborz University of Medical Sciencs 2015-11-01
Series:	Bihdād
Subjects:	Alpha blockers Anticholinergics Benign Prostate hyperplasia
Online Access:	http://aums.abzums.ac.ir/browse.php?a_code=A-10-1-120&slc_lang=en&sid=1

Similar Items

Is There Any Benefit Adding Anticholinergics to Drug Regime of Patients with Benign Prostate Hyperplasia?
by: A. Mortazavi, et al.
Published: (2015-08-01)

CURRENT OPPORTUNITIES FOR COMBINATION TREATMENT OF LOWER URINARY TRACT SYMPTOMS DUE TO BENIGN PROSTATIC HYPERPLASIA IN MEN
by: G. R. Kasyan, et al.
Published: (2016-06-01)

USING THE ORIGINAL ALPHA-1-BLOCKERS AND THEIR GENERIC IN CLINICAL UROLOGICAL PRACTICE
by: V. V. Borisov
Published: (2013-09-01)

The Efficacy of Solifenacin Added to Α-Adrenergic Antagonists in the Treatment of Lower Urinary Tract Symptoms in Males with Benign Prostate Hyperplasia (The Iraqi Experience)
by: Nibbras I. AL-Hamdani, et al.
Published: (2015-07-01)

Benign prostatic hyperplasia: clinical treatment can complicate cataract surgery
by: Fernando Facio, et al.
Published: (2010-10-01)

‘Tamsulosin and Darifenacin’ Versus ‘Tamsulosin Monotherapy’ for ‘BPH with Accompanying Overactive Bladder’
by: IQBAL SINGH, et al.
Published: (2015-06-01)

A comparison of the efficacy of naftopidil and tamsulosin hydrochloride in medical treatment of benign prostatic enlargement
by: Chenthil Perumal, et al.
Published: (2015-01-01)

Determination of Antibodies (IgG, IgM) against Toxoplasma gondii in Patients with Cancer
by: M Pedram, et al.
Published: (2007-08-01)

Determination of Antibodies (IgG, IgM) against Toxoplasma gondii in Patients with Cancer
by: M Ghasemian, et al.
Published: (2007-12-01)

Personalized therapeutics of α1-blockers in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia
by: Zhu LL, et al.
Published: (2015-03-01)

Three-year outcome analysis of alpha 1-blocker naftopidil for patients with benign prostatic hyperplasia in a prospective multicenter study in Japan
by: Masumori N, et al.
Published: (2016-07-01)

Is Early Surgical Treatment for Benign Prostatic Hyperplasia Preferable to Prolonged Medical Therapy: Pros and Cons
by: Cora Fogaing, et al.
Published: (2021-04-01)

The Relations Between Anti-Toxoplasma IgG and IgM Antibodies With Avidity Index
by: Saeedeh Shojaee, et al.
Published: (2017-10-01)

Clinical Efficacy of Transurethral Resection of the Prostate Combined with Oral Anticholinergics or Botulinum Toxin – A Injection to Treat Benign Prostatic Hyperplasia with Overactive Bladder: A Case–Control Study
by: Allameh F, et al.
Published: (2020-06-01)

The prostatic urethral angle can predict the response to alpha adrenoceptor antagonist monotherapy for treating nocturia in men with lower urinary tract symptom: A multicenter study
by: Byung Hoon Kim, et al.
Published: (2016-03-01)

Transurethral resection of the prostate provides more favorable clinical outcomes compared with conservative medical treatment in patients with urinary retention caused by benign prostatic obstruction
by: Yu-Hsiang Lin, et al.
Published: (2018-01-01)

Significant intravesical prostatic protrusion and prostatic calcification predict unfavorable outcomes of medical treatment for male lower urinary tract symptoms
by: Chia-Hao Kuei, et al.
Published: (2016-03-01)

Efficacy and safety of a combined use of alpha1-blocker doxazosin and phosphodiesterase-5 inhibitor udenafil in patients with benign prostatic hyperplasia
by: S. K. Martazinova, et al.
Published: (2014-11-01)

Efficacy and safety of a combined use of alpha1-blocker doxazosin and phosphodiesterase-5 inhibitor udenafil in patients with benign prostatic hyperplasia
by: S. K. Martazinova, et al.
Published: (2014-11-01)

The role of IgM and IgG anti-toxoplasma gondii in abortion
by: Massoud A, et al.
Published: (1993-04-01)

Medical management of patients with benign prostatic hyperplasia: A study in Indian population
by: Amit Kumar Shah, et al.
Published: (2018-01-01)

Frequency of anti- Toxoplasma gondii IgA, IgM, and IgG antibodies in high-risk pregnancies, in Brazil
by: Fernando Henrique Antunes Murata, et al.

Point-of-care testing for Toxoplasma gondii IgG/IgM using Toxoplasma ICT IgG-IgM test with sera from the United States and implications for developing countries.
by: Ian J Begeman, et al.
Published: (2017-06-01)

Recent advances in managing chronic prostatitis/chronic pelvic pain syndrome [version 1; referees: 2 approved]
by: Jaspreet Sandhu, et al.
Published: (2017-09-01)

DIFFERENCES IN THE EFFECTIVENESS OF SELECTIVE ALPHA BLOCKER THERAPY COMBINED WITH 5-ALPHA REDUCTASE INHIBITOR ON IPSS VALUE OF BPH LUTS PATIENTS
by: Septa Surya Wahyudi, et al.
Published: (2020-07-01)

Giant prostatic hyperplasia: Case report and literature review
by: Oktay Üçer, et al.
Published: (2011-12-01)

QUALITY OF LIFE AFTER PROSTATECTOMY
by: Darko Laketić
Published: (2005-07-01)

Prevalence of IgG and IgM anti-Toxoplasma antibodies in patients with HIV and acquired immunodeficiency syndrome (AIDS)
by: María de la Luz Galván Ramírez, et al.
Published: (1997-12-01)

Results of anti-Toxoplasma gondii IgG, IgM, IgA and IgG Avidity testing in pregnant women in Rome, Italy
by: Carla Nisii, et al.
Published: (2012-12-01)

Differential expression of 5-alpha reductase isozymes in the prostate and its clinical implications
by: Kai Wang, et al.
Published: (2014-04-01)

Detection of specific IgG, IgM, IgE and IgG subclass antibodies for serological diagnosis of human cystic echinococcosis
by: Naik M. I., et al.
Published: (2015-06-01)

Rapid versus gradual bladder decompression in acute urinary retention
by: Mohamed H Etafy, et al.
Published: (2017-01-01)

Tamsulosin and Dementia in old age: is there any relationship?
by: Rebecca Renata Lapenda do Monte, Karina de Andrade Vidal Costa, Arnaldo Santiago Nunes Junior, Am lia Cinthia Meneses R go, Irami Ara jo Filho
Published: (2019-10-01)

Symptomatic benign prostatic hyperplasia: the role of 5-alpha-reductase inhibitors in the prevention of acute urinary retention and surgical therapy
by: Norma Marigliano, et al.
Published: (2012-01-01)

Determination of Antibodies (IgG, IgM) against Toxoplasma gondii in Some Iraqi individuals by using ELISA technique
by: Baghdad Science Journal
Published: (2011-12-01)

Competition between serum IgG, IgM, and IgA anti-glycan antibodies.
by: Saddam M Muthana, et al.
Published: (2015-01-01)

Effect of KTP Laser Made byAEOI on Resected Prostateafter Open Prostatectomy
by: MR Razzaghi, et al.
Published: (2008-07-01)

Could pollen extract in association with vitamins be favorable in the reduction of chronic prostatic inflammation? A case-series analysis
by: Michele Zazzara, et al.
Published: (2019-07-01)

Predicting Significance of Blood Parameters in Diagnosis of Prostate Carcinoma in a Tertiary Centre in Udaipur, Rajasthan
by: Gulshan Kumar Mukhiya, et al.
Published: (2021-04-01)

A Comparative Study on Sensitivity and Specificity of Conventional and Unconventional IgG and IgM Assays for Diagnosis of Toxoplasmosis
by: MJ Gharavi, et al.
Published: (2008-12-01)